AstraZeneca PLC (AZN)

AstraZeneca plc is a British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%

Regeneron's (REGN) share price rose after it reported data from a late-stage study showing that treatment with Dupixent led to a 30% decline in chronic obstructive pulmonary disease exacerbations....

Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should Know

Astrazeneca (AZN) closed the most recent trading day at $67.26, moving +1.04% from the previous trading session....

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates....

3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030

These historically profitable dividend-paying stocks are ideal for risk-averse investors wanting to take advantage of a bear market discount....

Here's What is Driving Amgen (AMGN) Stock's Outperformance

Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. It is also rapidly advancing its robust pipeline....

Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.